282 related articles for article (PubMed ID: 31403185)
1. HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits.
Yaşar O; Karatayli E; Cengiz G; Kızılpınar M; Yurdcu E; Albayrak R; Güven A; Arslan Ö; Karahan C; Otlu B; Güdücüoğlu H; Gökahmetoğlu S; Berk E; Kirişci Ö; Sertöz R; Yurdaydin C; Bozdayi AM; Karatayli SC
J Med Virol; 2019 Dec; 91(12):2174-2181. PubMed ID: 31403185
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of the hepatitis E virus seroprevalence in cases admitted to Hacettepe University Medical Faculty Hospital].
Aydın NN; Ergünay K; Karagül A; Pınar A; Us D
Mikrobiyol Bul; 2015 Oct; 49(4):554-64. PubMed ID: 26649413
[TBL] [Abstract][Full Text] [Related]
3. Estimation of the hepatitis E assay-dependent seroprevalence among Croatian blood donors.
Miletić M; Vuk T; Hećimović A; Stojić Vidović M; Jemeršić L; Jukić I
Transfus Clin Biol; 2019 Nov; 26(4):229-233. PubMed ID: 31277986
[TBL] [Abstract][Full Text] [Related]
4. Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors.
Al-Absi ES; Al-Sadeq DW; Younis MH; Yassine HM; Abdalla OM; Mesleh AG; Hadwan TA; Amimo JO; Thalib L; Nasrallah GK
J Med Microbiol; 2018 Sep; 67(9):1302-1309. PubMed ID: 30051802
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donors.
Petrović T; Lupulović D; Jiménez de Oya N; Vojvodić S; Blázquez AB; Escribano-Romero E; Martín-Acebes MA; Potkonjak A; Milošević V; Lazić S; Saiz JC
J Infect Dev Ctries; 2014 Oct; 8(10):1322-7. PubMed ID: 25313610
[TBL] [Abstract][Full Text] [Related]
6. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries.
Bendall R; Ellis V; Ijaz S; Ali R; Dalton H
J Med Virol; 2010 May; 82(5):799-805. PubMed ID: 20336757
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis E virus infection in Hong Kong blood donors.
Tsoi WC; Zhu X; To AP; Holmberg J
Vox Sang; 2020 Jan; 115(1):11-17. PubMed ID: 31709559
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis E virus (HEV) in Scotland: evidence of recent increase in viral circulation in humans.
Thom K; Gilhooly P; McGowan K; Malloy K; Jarvis LM; Crossan C; Scobie L; Blatchford O; Smith-Palmer A; Donnelly MC; Davidson JS; Johannessen I; Simpson KJ; Dalton HR; Petrik J
Euro Surveill; 2018 Mar; 23(12):. PubMed ID: 29589577
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis E virus epidemiology in adult population in Edirne province, Turkey].
Eker A; Tansel O; Kunduracilar H; Tokuç B; Yuluğkural Z; Yüksel P
Mikrobiyol Bul; 2009 Apr; 43(2):251-8. PubMed ID: 19621610
[TBL] [Abstract][Full Text] [Related]
10. Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016.
Niederhauser C; Widmer N; Hotz M; Tinguely C; Fontana S; Allemann G; Borri M; Infanti L; Sarraj A; Sigle J; Stalder M; Thierbach J; Waldvogel S; Wiengand T; Züger M; Gowland P
Euro Surveill; 2018 Aug; 23(35):. PubMed ID: 30180927
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west-central Poland.
Bura M; Łagiedo M; Michalak M; Sikora J; Mozer-Lisewska I
Int J Infect Dis; 2017 Aug; 61():20-22. PubMed ID: 28576599
[TBL] [Abstract][Full Text] [Related]
12. A Nationwide Survey of the Seroprevalence of Hepatitis E Virus Infections Among Blood Donors in Thailand.
Jupattanasin S; Chainuvati S; Chotiyaputta W; Chanmanee T; Supapueng O; Charoonruangrit U; Oota S; Louisirirotchanakul S
Viral Immunol; 2019 Sep; 32(7):302-307. PubMed ID: 31403386
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA
J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India.
Katiyar H; Goel A; Sonker A; Yadav V; Sapun S; Chaudhary R; Aggarwal R
Indian J Gastroenterol; 2018 Jul; 37(4):342-346. PubMed ID: 30159666
[TBL] [Abstract][Full Text] [Related]
15. Performance Evaluation of Different Commercial Serological Kits for Diagnosis of Acute Hepatitis E Viral Infection.
Zhang Q; Zong X; Li D; Lin J; Li L
Pol J Microbiol; 2020 Sep; 69(2):217-222. PubMed ID: 32548990
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis E virus seroprevalence among blood donors in Pune, India.
Tripathy AS; Puranik S; Sharma M; Chakraborty S; Devakate UR
J Med Virol; 2019 May; 91(5):813-819. PubMed ID: 30489644
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial Assays.
Pischke S; Schwarze-Zander C; Bremer B; Lehmann P; Wiegand SB; Gisa A; Behrendt P; Strassburg CP; Manns MP; Wedemeyer H; Rockstroh JK
Intervirology; 2015; 58(5):283-7. PubMed ID: 26625157
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.
Lucarelli C; Spada E; Taliani G; Chionne P; Madonna E; Marcantonio C; Pezzotti P; Bruni R; La Rosa G; Pisani G; Dell'Orso L; Ragone K; Tomei C; Ciccaglione AR
Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494608
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso.
Traoré KA; Rouamba H; Nébié Y; Sanou M; Traoré AS; Barro N; Roques P
PLoS One; 2012; 7(10):e48125. PubMed ID: 23110187
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence and Incidence of hepatitis E in blood donors in Upper Austria.
Fischer C; Hofmann M; Danzer M; Hofer K; Kaar J; Gabriel C
PLoS One; 2015; 10(3):e0119576. PubMed ID: 25751574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
